An old molecule to fight SARS-CoV-2
Université de Montréal News | Feb 11, 2022
Almost 1 in 3 older adults develop new conditions after COVID-19 infection
MedicalXpress Breaking News-and-Events | Feb 11, 2022
Using high-resolution, single-cell profiling to understand immune response in severe COVID-19
MedicalXpress Breaking News-and-Events | Feb 11, 2022
Most people with prior SARS-Cov-2 infection or vaccination have t cell immune responses against Omicron variant: study
MedicalXpress Breaking News-and-Events | Feb 10, 2022
Protracted inflammation linked to post-COVID lung problems
Newswise | Feb 10, 2022
Protective mutations in COVID-19
MedicalXpress Breaking News-and-Events | Feb 10, 2022
Antihistamines show promise in treating long COVID-19 symptoms, UCI case report says
Newswise | Feb 10, 2022
COVID-19-associated strokes link to higher disability and death risk, study finds
ScienceDaily | Feb 10, 2022
Separating COVID-19 fact from fiction
Mayo Clinic | Feb 10, 2022
Results of first clinical trial of niclosamide antiviral in patients with COVID-19 show further research needed
MedicalXpress Breaking News-and-Events | Feb 10, 2022
A variety of information related to Medicine and Health Care. It's all here.
